Interesting facts
Interesting Facts about 2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
The compound 2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol is an intriguing molecule that bridges the worlds of biology and chemistry due to its structural similarity to nucleotides, the building blocks of DNA and RNA. Here are some fascinating points about this compound:
- Nucleobase Connection: This compound resembles purine, a fundamental component of nucleic acids. Its presence is crucial in the synthesis of DNA and RNA, thus playing a pivotal role in genetic coding.
- Hydroxymethyl Group: The presence of the hydroxymethyl group can influence the reactivity and biological profile of the compound. This feature may enhance its potential interactions with biological molecules.
- Potential Applications: Compounds like this one are often investigated for their role in medicine, particularly in the development of antiviral and anticancer therapies. The structural characteristics may aid in drug design, targeting specific biological pathways.
- Synthetic Pathways: The synthetic methods used to create such compounds can offer insights into organic chemistry techniques. Understanding these pathways can lead to advancements in chemical synthesis and encourage innovation in related fields.
- Bioactivity Exploration: Research in pharmacology may uncover potential bioactivities, including how it interacts with enzymes or receptors. Exploring these interactions can lead to discoveries of new therapeutic uses.
In summary, 2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol embodies a fascinating intersection of chemistry and biology, with its potential implications in the fields of medicine and pharmacology continuing to inspire researchers.
Synonyms
2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
3228-71-5
Adenosine-13C5
.beta.-Adenosine
2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
Xylosyladenine
MLS000699527
4005-33-8
9-Xylosyladenine
Xylosyl A
9-Arabinosyladenine
NSC70422
NSC247519
NSC404241
123179-97-5
SMR000225041
.beta.-D-Arabinosyladenine
NSC87676; beta-L-Adenosine
9.beta.-D-Arabinofuranosyladenine
Adenine .beta.-d-arabinofuranoside
Adenine 9-beta-D-arabinofuranoside
9-pentofuranosyl-9H-purin-6-amine
NSC 7359
.beta.-D-Adenosine
Adenine, 9-.alpha.-D-xylofuranosyl-
Adenine, 9.beta.-D-arabinofuranosyl-
2946-52-3
9-alpha-L-Ribofuranosyl-9H-purin-6-amine
9-alpha-Ribofuranosyladenine
9H-Purin-6-amine, 9-.alpha.-D-xylofuranosyl-
9H-Purin-6-amine, 9.beta.-D-arabinofuranosyl-
4185-03-9
NSC7359
9-.alpha.-D-Xylofuranosyladenine
.beta.-D-Ribofuranoside, adenine-9
9-.alpha.-D-Arabinofuranosyladenine
NSC 404241
XA
Adenosine-8-14C
VIRDARABINE
6-Amino-9.beta.-D-ribofuranosyl-9H-purine
Adenine, 9-.alpha.-D-arabinofuranosyl-
9H-Purin-6-amine, 9-b-D-lyxofuranosyl-
Opera_ID_164
9-.beta.-Arabinoadenosine
REGID_for_CID_191
9-.beta.-Arabinosyladenine
NCIOpen2_003303
NCIOpen2_005376
SCHEMBL63363
ZCCY002
.beta.-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-
9H-Purin-6-amine, 9-.alpha.-D-arabinofuranosyl-
MLS006011831
CHEMBL11909
9.beta.-D-Ribofuranosyladenine
Adenine-9-b-D-arabinofuranoside
SCHEMBL20419324
9-.beta.-D-Xylofuranosyladenine
CHEBI:93913
.alpha.-D-Arabinofuranosyladenine
(2S,3S,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
ARA-A NSC 247519
OIRDTQYFTABQOQ-UHFFFAOYSA-N
BDBM199118
HMS2688C17
HMS3369A21
HMS3372M16
HMS3374D06
HMS3655A12
HMS3655G15
HMS3755C13
Adenine-.beta.-D-arabinofuranoside
9-.beta.-D-Arabinofuranosyladenine
BCP25434
BCP32271
NSC-7359
NSC80832
NSC87676
NSC91041
Adenine, 9-.beta.-D-xylofuranosyl-
BBL007185
MFCD28053745
NSC-70422
NSC-80832
NSC-87676
NSC-91041
STK361815
Adenine-9-.beta.-D-arabinofuranoside
AKOS005429469
NSC-627048
Adenine, 9-.beta.-D-arabinofuranosyl-
NCGC00015103-03
NCGC00015103-04
NCGC00015103-05
NCGC00015103-06
NCGC00094579-01
NCGC00094579-02
NCGC00094579-03
NCGC00094579-04
AS-69806
NCI60_003823
NCI60_037192
SY001357
SY104375
6-Amino-9-.beta.-D-arabinofuranosylpurine
DB-052972
DB-124990
NS00010570
9H-Purin-6-amine, 9.beta.-D-ribofuranosyl-
Beta-L-adenosine pound>>(c)micro-L-Adenosine
9H-Purin-6-amine, 9-.beta.-D-xylofuranosyl-
EN300-297293
L000094
F2ECA788-2ABC-49AB-AD84-0A0759DD3A91
Q27165666
WLN: T56 BN DN FN HNJ IZ D- BT5OTJ CQ DQ E1Q
Z275361680
Adenosine free base, Bacterial Endotoxins ≤ 50 EU/100g
alpha-Adenosine;9-?(c) paragraph sign-?D-?ribofuranosyl-9H-?Purin-?6-?amine
Solubility of 2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
The solubility of the compound 2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol (C10H13N5O4) can be influenced by several factors:
In summary, one can speculate that 2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol is likely to be more soluble in polar solvents, particularly water, compared to non-polar solvents. However, experimental data would be necessary to confirm its definitive solubility characteristics.